Effect of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor on Disease Activity in Patients With Rheumatoid Arthritis: A Meta-Analysis

HMG-CoA reductase inhibitors (also known as statins) are widely used as lipid-lowering agents in patients with rheumatoid arthritis (RA) to reduce their cardiovascular risk. However, whether they have an effect on RA disease activity is controversial. This study aimed to investigate the effect of st...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Bin, Yin, Yu-Feng, Zhao, Li-Dan, Wang, Li, Zheng, Wen-Jie, Chen, Hua, Wu, Qing-Jun, Tang, Fu-Lin, Zhang, Feng-Chun, Shan, Guangliang, Zhang, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554148/
https://www.ncbi.nlm.nih.gov/pubmed/25715256
http://dx.doi.org/10.1097/MD.0000000000000572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554148/
https://www.ncbi.nlm.nih.gov/pubmed/25715256
http://dx.doi.org/10.1097/MD.0000000000000572

Ejemplares similares